Prognostic role of interferon ‐lambda 3 in anti‐MDA5–positive dermatomyositis‐associated ILD

ConclusionSerum IFN- λ3 is a promising biomarker for identifying patients at high risk of poor outcomes in anti-MDA5 antibody-positive DM-ILD.This article is protected by copyright. All rights reserved.

Source: Arthritis and Rheumatology - December 26, 2023 Category: Rheumatology Authors: Atsuki Fukada, Tomoyuki Fujisawa, Hironao Hozumi, Keigo Koda, Taisuke Akamatsu, Yoshiyuki Oyama, Yasuomi Satake, Mitsuru Niwa, Yusuke Kaida, Hiroyuki Matsuda, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Dai Hashimoto, A Tags: Full Length Source Type: research